AccScience Publishing / TD / Volume 2 / Issue 2 / DOI: 10.36922/td.1057
Cite this article
138
Download
1613
Views
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
REVIEW

Choroid plexus tumors: A spectrum from benign to malignant

Ali A. Mohamed1 Thomas Caussat1 Sophie Kelly1 Phillip M. Johansen2 Brandon Lucke-Wold3*
Show Less
1 Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA
2 Department of Neurosurgery, University of South Florida, Orlando, Florida, USA
3 Department of Neurosurgery, University of Florida, Gainesville, Florida, USA
Tumor Discovery 2023, 2(2), 1057 https://doi.org/10.36922/td.1057
Submitted: 8 June 2023 | Accepted: 28 July 2023 | Published: 18 August 2023
© 2023 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Choroid plexus tumors (CPT) are believed to originate from outgrowths of the choroid plexus. Despite their broad spectrum of symptoms, invasive nature, and prognosis, most CPTs typically exhibit similar presentations due to their relationship with the cerebral ventricles, as well as the mechanical obstruction and mass effect associated with their growth. In addition, these tumors mainly affect the pediatric population, further complicating the differentiation between benign and malignant subtypes. The World Health Organization classifies CPTs into three grades, namely, grades I, II, or III, based on their mitotic activity, which determine the benign or malignant nature of the tumors. CPTs classified by the World Health Organization (WHO) include choroid plexus papillomas (CPP), atypical CPPs (aCPP), and malignant choroid plexus carcinomas (CPC). Choroid plexus adenomas represent an additional category of benign CPTs not officially classified by the WHO. Despite the variations in histology, immunohistochemistry, imaging, treatment, and prognosis, CPTs cannot be reliably distinguished based solely on clinical presentation. Therefore, in this review, we aim to provide a comprehensive overview of each tumor subtype, along with the current management approach and emerging treatments.

Keywords
Choroid plexus
Choroid plexus tumors
Choroid plexus adenoma
Choroid plexus papilloma
Choroid plexus carcinoma
Funding
None.
References
  1. Wolburg H, Paulus W, 2010, Choroid plexus: Biology and pathology. Acta Neuropathol, 119(1): 75–88. https://doi.org/10.1007/s00401-009-0627-8

 

  1. Gopal P, Parker JR, Debski R, et al., 2008, Choroid plexus carcinoma. Arch Pathol Lab Med, 132(8): 1350–1354. https://doi.org/10.5858/2008-132-1350-CPC

 

  1. Wolff JEA, Sajedi M, Brant R, et al., 2002, Choroid plexus tumours. Br J Cancer, 87(10): 1086–1091. https://doi.org/10.1038/sj.bjc.6600609

 

  1. Ruiz-Garcia H, Huayllani MT, Incontri D, et al., 2020, Intraventricular choroid plexus tumors: Clinical characteristics and impact of current management on survival. J Neurooncol, 149(2): 283–292. https://doi.org/10.1007/s11060-020-03603-8

 

  1. Jaiswal S, Vij M, Mehrotra A, et al., 2013, Choroid plexus tumors: A clinico-pathological and neuro-radiological study of 23 cases. Asian J Neurosurg, 8(1): 29–35. https://doi.org/10.4103/1793-5482.110277

 

  1. Hasselblatt M, Böhm C, Tatenhorst L, et al., 2006, Identification of novel diagnostic markers for choroid plexus tumors: A microarray-based approach. Am J Surg Pathol, 30(1): 66–74. https://doi.org/10.1097/01.PAS.0000176430.88702.E0

 

  1. Raimondi AJ, Gutierrez FA, 1975, Diagnosis and surgical treatment of choroid plexus papillomas. Pediatr Neurosurg, 1(2–3): 81–115. https://doi.org/10.1159/000119558

 

  1. Zhou WJL, Wang X, Peng JY, et al., 2018, Clinical features and prognostic risk factors of choroid plexus tumors in children. Chin Med J (Engl), 131(24): 2938–2946. https://doi.org/10.4103/0366-6999.247195

 

  1. Prendergast N, Goldstein JD, Beier AD, 2018, Choroid plexus adenoma in a child: Expanding the clinical and pathological spectrum. J Neurosurg Pediatr, 21(4): 428–433. https://doi.org/10.3171/2017.10.PEDS17290

 

  1. Ajir F, Chanbusarakum K, Craig Bolles J, 1982, Acinar choroid plexus adenoma of the fourth ventricle. Surg Neurol, 17(4): 290–292. https://doi.org/10.1016/0090-3019(82)90125-2

 

  1. Andreini L, Doglioni C, Giangaspero F, 1991, Tubular adenoma of choroid plexus: A case report. Clin Neuropathol, 10(3): 137–140.

 

  1. Duckett S, Osterholm J, Schaefer D, et al., 1991, Ossified mucin-secreting choroid plexus adenoma: Case report. Neurosurgery, 29(1): 130–132. https://doi.org/10.1227/00006123-199107000-00024

 

  1. Eljamel MSM, Jeffreys RV, 1990, Mucous-secreting choroid plexus adenoma - case report and review of the literature. Neuropediatrics, 21(1): 55–56. https://doi.org/10.1055/s-2008-1071460

 

  1. Rembao-Bojórquez D, Vega R, Bermúdez-Maldonado L, et al., 2007, Choroid plexus acinar adenoma: A case report. J Neurooncol, 83(2): 191–197. https://doi.org/10.1007/s11060-006-9304-0

 

  1. Urbach H, Grote A, Niehusmann P, et al., 2010, Choroid plexus adenoma of the fourth ventricle: High-resolution MRI. Clin Neuroradiol, 20(2): 113–115. https://doi.org/10.1007/s00062-010-0003-z

 

  1. Sutton LN, Golden JA, Needle M, et al., 1998, Surgical removal of a choroid plexus adenoma using the argon beam coagulator: Technical case report. Neurosurgery, 43(1): 171–173. https://doi.org/10.1097/00006123-199807000-00119

 

  1. Varga Z, Vajtai I, Marino S, et al., 1996, Tubular adenoma of the choroid plexus: Evidence for glandular differentiation of the neuroepithelium. Pathol Res Pract, 192(8): 840–844. https://doi.org/10.1016/S0344-0338(96)80058-6

 

  1. Yung WKA, 2002, Pathology and genetics of tumours of the nervous system. Neuro Oncol, 4(1): 51–52. https://doi.org/10.1215/15228517-4-1-51

 

  1. Esiri M, 2000, Russell and Rubinstein’s pathology of tumors of the nervous system. Sixth edition. J Neurol Neurosurg Psychiatry, 68(4): 538D. https://doi.org/10.1136/jnnp.68.4.538d

 

  1. Hoenig EM, Ghatak NR, Hirano A, et al., 1967, Multiloculated cystic tumor of the choroid plexus of the fourth ventricle. Case report. J Neurosurg, 27(6): 574–579. https://doi.org/10.3171/jns.1967.27.6.0574

 

  1. Aquilina K, Nanra JS, Allcutt DA, et al., 2005, Choroid plexus adenoma: Case report and review of the literature. Childs Nerv Syst, 21(5): 410–415. https://doi.org/10.1007/s00381-004-1038-8

 

  1. Louis DN, Perry A, Wesseling P, et al., 2021, The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol, 23(8): 1231–1251. https://doi.org/10.1093/neuonc/noab106

 

  1. Komori T, 2017, The 2016 WHO classification of tumours of the central nervous system: The major points of revision. Neurol Med Chir (Tokyo), 57(7): 301–311. https://doi.org/10.2176/nmc.ra.2017-0010

 

  1. Bettegowda C, Adogwa O, Mehta V, et al., 2012, Treatment of choroid plexus tumors: A 20-year single institutional experience. J Neurosurg Pediatr, 10(5): 398–405. https://doi.org/10.3171/2012.8.PEDS12132

 

  1. Sasani M, Solmaz B, Oktenoglu T, et al., 2014, An unusual location for a choroid plexus papilloma: The pineal region. Childs Nerv Syst, 30(7): 1307–1377. https://doi.org/10.1007/s00381-014-2361-3

 

  1. Paulus W, Jänisch W, 1990, Clinicopathologic correlations in epithelial choroid plexus neoplasms: A study of 52 cases. Acta Neuropathol, 80(6): 635–641. https://doi.org/10.1007/BF00307632

 

  1. Louis DN, Ohgaki H, Wiestler OD, et al., 2007, The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 114(2): 97–109. https://doi.org/10.1007/s00401-007-0243-4

 

  1. Koh EJ, Wang KC, Phi JH, et al., 2014, Clinical outcome of pediatric choroid plexus tumors: Retrospective analysis from a single institute. Childs Nerv Syst, 30(2): 217–225. https://doi.org/10.1007/s00381-013-2223-4

 

  1. Zhen HN, Zhang X, Bu XY, et al., 1999, Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRB complexes in human brain tumors. Cancer, 86(10): 2124–2132. https://doi.org/10.1002/(SICI)1097-0142(19991115)86: 10<2124:AID-CNCR34>3.0.CO;2-D

 

  1. Okamoto H, Mineta T, Ueda S, et al., 2005, Detection of JC virus DNA sequences in brain tumors in pediatric patients. J Neurosurg, 102: 294–298. https://doi.org/10.3171/ped.2005.102.3.0294

 

  1. Pianetti Filho G, Fonseca LF, Da Silva MC, 2002, Choroid plexus papilloma and Aicardi syndrome: Case report. Arq Neuropsiquiatr, 60(4): 1008–1010. https://doi.org/10.1590/S0004-282X2002000600023

 

  1. Aguiar MDFM, Cavalcanti M, Barbosa H, et al., 1996, Aicardi syndrome and choroid plexus papilloma: A rare association. Case report. Arq Neuropsiquiatr, 54(2): 313–317. https://doi./org/10.1590/s0004-282x1996000200022

 

  1. Vadivelu S, Edelman M, Schneider SJ, et al., 2013, Choroid plexus papilloma and Pierpont syndrome: Case report. J Neurosurg Pediatr, 11(2): 115–118. https://doi.org/10.3171/2012.10.PEDS12219

 

  1. Tabori U, Shlien A, Baskin B, et al., 2010, TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol, 28(12): 1995–2001. https://doi.org/10.1200/JCO.2009.26.8169

 

  1. Yankelevich M, Finlay JL, Gorsi H, et al., 2021, Molecular insights into malignant progression of atypical choroid plexus papilloma. Cold Spring Harb Mol Case Stud, 7(1): a005272. https://doi.org/10.1101/MCS.A005272

 

  1. Ruggeri L, Alberio N, Alessandrello R, et al., 2018, Rapid malignant progression of an intraparenchymal choroid plexus papillomas. Surg Neurol Int, 9(1): 131. https://doi.org/10.4103/sni.sni_434_17

 

  1. Khade S, Shenoy A, 2018, Ectopic choroid plexus papilloma. Asian J Neurosurg, 13(1): 191–194. https://doi.org/10.4103/1793-5482.185067

 

  1. Ikota H, Tanaka Y, Yokoo H, et al., 2011, Clinicopathological and immunohistochemical study of 20 choroid plexus tumors: Their histological diversity and the expression of markers useful for differentiation from metastatic cancer. Brain Tumor Pathol, 28: 215–221. https://doi.org/10.1007/s10014-011-0024-6

 

  1. Kurtkaya-Yapicier O, Scheithauer BW, Van Peteghem KP, et al., 2002, Unusual case of extradural choroid plexus papilloma of the sacral canal. Case report. J Neurosurg, 97(1 Suppl): 102–105. https://doi.org/10.3171/spi.2002.97.1.0102

 

  1. Beskonakli E, 1998, Choroid plexus papillomas of the posterior fossa: Extraventricular extension, intraventricular and primary extraventricular location: Report of four cases. J Neurosurg Sci, 42(1): 37–40.

 

  1. Matson DD, Crofton FD, 1960, Papilloma of the choroid plexus in childhood. J Neurosurg, 17: 1002–1027. https://doi.org/10.3171/jns.1960.17.6.1002

 

  1. Pillai A, Rajeev K, Chandi S, et al., 2004, Intrinsic brainstem choroid plexus papilloma: Case report. J Neurosurg, 100(6): 1076–1078. https://doi.org/10.3171/jns.2004.100.6.1076

 

  1. Sarkar C, Sharma MC, Gaikwad S, et al., 1999, Choroid plexus papilloma: A clinicopathological study of 23 cases. Surg Neurol, 52(1): 37–39. https://doi.org/10.1016/S0090-3019(99)00049-X

 

  1. Nakano I, Kondo A, Iwasaki K, 1997, Choroid plexus papilloma in the posterior third ventricle: Case report. Neurosurgery, 40(6): 1279–1282. https://doi.org/10.1097/00006123-199706000-00030

 

  1. Piguet V, De Tribolet N, 1984, Choroid plexus papilloma of the cerebellopontine angle presenting as a subarachnoid hemorrhage: Case report. Neurosurgery, 15(1): 114–116. https://doi.org/10.1227/00006123-198407000-00023

 

  1. Mula-Hussain L, Malone J, Dos Santos MP, et al., 2021, CSF rhinorrhea: A rare clinical presentation of choroid plexus papilloma. Curr Oncol, 28(1): 750–756. https://doi.org/10.3390/curroncol28010073

 

  1. Jamjoom AAB, Sharab MA, Jamjoom AB, et al., 2009, Rapid evolution of a choroid plexus papilloma in an infant. Br J Neurosurg, 23(3): 324–325. https://doi.org/10.1080/02688690902756694

 

  1. Li Y, Chetty S, Feldstein VA, et al., 2021, Bilateral choroid plexus papillomas diagnosed by prenatal ultrasound and MRI. Cureus, 13: e13737. https://doi.org/10.7759/cureus.13737

 

  1. Cao LR, Chen J, Zhang RP, et al., 2018, Choroid plexus papilloma of bilateral lateral ventricle in an infant conceived by in vitro fertilization. Pediatr Neurosurg, 53(6): 401–406. https://doi.org/10.1159/000491639

 

  1. Dangouloff-Ros V, Grevent D, Pagès M, et al., 2015, Choroid plexus neoplasms: Toward a distinction between carcinoma and papilloma using arterial spin-labeling. Am J Neuroradiol, 36(9): 1786–1790. https://doi.org/10.3174/ajnr.A4332

 

  1. Pandey SK, Mani SE, Sudhakar SV, et al., 2019, Reliability of imaging-based diagnosis of lateral ventricular masses in children. World Neurosurg, 124: e693–e701. https://doi.org/10.1016/j.wneu.2018.12.196

 

  1. Turkoglu E, Kertmen H, Sanli AM, et al., 2014, Clinical outcome of adult choroid plexus tumors: Retrospective analysis of a single institute. Acta Neurochir (Wien), 156(8): 1461–1468. https://doi.org/10.1007/s00701-014-2138-1

 

  1. Kim IY, Niranjan A, Kondziolka D, et al., 2008, Gamma knife radiosurgery for treatment resistant choroid plexus papillomas. J Neurooncol, 90(1): 105–110. https://doi.org/10.1007/s11060-008-9639-9

 

  1. Laarakker AS, Nakhla J, Kobets A, et al., 2017, Incidental choroid plexus papilloma in a child: A difficult decision. Surg Neurol Int, 8: 86. https://doi.org/10.4103/sni.sni_386_16

 

  1. Ito H, Nakahara Y, Kawashima M, et al., 2017, Typical symptoms of normal-pressure hydrocephalus caused by choroid plexus papilloma in the cerebellopontine angle. World Neurosurg, 98: 875.e13. https://doi.org/10.1016/j.wneu.2016.11.106

 

  1. Jung GS, Ruschel LG, Leal AG, et al., 2016, Embolization of a giant hypervascularized choroid plexus papilloma with onyx by direct puncture: A case report. Childs Nerv Syst, 32(4): 717–721. https://doi.org/10.1007/s00381-015-2915-z

 

  1. Aljared T, Farmer JP, Tampieri D, 2016, Feasibility and value of preoperative embolization of a congenital choroid plexus tumour in the premature infant: An illustrative case report with technical details. Interv Neuroradiol, 22(6): 732–735. https://doi.org/10.1177/1591019916665346

 

  1. Toescu SM, James G, Phipps K, et al., 2019, Intracranial neoplasms in the first year of life: Results of a third cohort of patients from a single institution. Clin Neurosurg, 84(3): 636–646. https://doi.org/10.1093/neuros/nyy081

 

  1. Dash C, Moorthy S, Garg K, et al., 2019, Management of choroid plexus tumors in infants and young children up to 4 years of age: An institutional experience. World Neurosurg, 121: e237–e245. https://doi.org/10.1016/j.wneu.2018.09.089

 

  1. Abdulkader MM, Mansour NH, Van Gompel JJ, et al., 2016, Disseminated choroid plexus papillomas in adults: A case series and review of the literature. J Clin Neurosci, 32: 148–154. https://doi.org/10.1016/j.jocn.2016.04.002

 

  1. Lechanoine F, Zemmoura I, Velut S, 2017, Treating Cerebrospinal fluid rhinorrhea without dura repair: A case report of posterior fossa choroid plexus papilloma and review of the literature. World Neurosurg, 108: 990. e1–990.e9. https://doi.org/10.1016/j.wneu.2017.08.121

 

  1. Ward C, Phipps K, De Sousa C, et al., 2009, Treatment factors associated with outcomes in children less than 3 years of age with CNS tumours. Childs Nerv Syst, 25(6): 663–668. htttps://doi.org/10.1007/s00381-009-0832-8

 

  1. Fujimura M, Unuma T, Kameyama M, et al., 2004, Hydrocephalus due to cerebrospinal fluid overproduction by bilateral choroid plexus papillomas. Childs Nerv Syst, 20(7): 485–488. https://doi.org/10.1007/s00381-003-0889-8

 

  1. Jeibmann A, Hasselblatt M, Gerss J, et al., 2006, Prognostic implications of atypical histologic features in choroid plexus papilloma. J Neuropathol Exp Neurol, 65(11): 1069–1073. https://doi.org/10.1097/01.jnen.0000240464.26005.90

 

  1. Goel K, Birdi U, Menaker S, et al., 2022, Atypical choroid plexus papilloma of the fourth ventricle in an adult: A case report. Cureus, 14: 25256. https://doi.org/10.7759/cureus.25256

 

  1. Wrede B, Hasselblatt M, Peters O, et al., 2009, Atypical choroid plexus papilloma: Clinical experience in the CPT-SIOP-2000 study. J Neurooncol, 95(3): 383–392. https://doi.org/10.1007/s11060-009-9936-y

 

  1. Lee SH, Park BJ, Kim EJ, et al., 2009, Atypical choroid plexus papilloma in an adult. J Korean Neurosurg Soc, 46(1): 74–76. https://doi.org/10.3340/jkns.2009.46.1.74

 

  1. Chen Y, Zhao R, Shi W, et al., 2021, Pediatric atypical choroid plexus papilloma: Clinical features and diagnosis. Clin Neurol Neurosurg, 200: 106345. https://doi.org/10.1016/j.clineuro.2020.106345

 

  1. Hosmann A, Hinker F, Dorfer C, et al., 2019, Management of choroid plexus tumors--an institutional experience. Acta Neurochir (Wien), 161(4): 745–754. https://doi.org/10.1007/s00701-019-03832-5

 

  1. Ma E, Wang J, Guan G, et al., 2016, Microsurgical treatment of atypical choroid plexus papilloma in the fourth ventricle. Acta Neurol Belg, 116(3): 413–414. https://doi.org/10.1007/s13760-015-0551-8

 

  1. Crea A, Bianco A, Cossandi C, et al., 2020, Choroid plexus carcinoma in adults: Literature review and first report of a location into the third ventricle. World Neurosurg, 133: 302–307. https://doi.org/10.1016/j.wneu.2019.10.051

 

  1. Cannon DM, Mohindra P, Gondi V, et al., 2015, Choroid plexus tumor epidemiology and outcomes: Implications for surgical and radiotherapeutic management. J Neurooncol, 121(1): 151–157. https://doi.org/10.1007/s11060-014-1616-x

 

  1. Carlotti CG, Salhia B, Weitzman S, et al., 2002, Evaluation of proliferative index and cell cycle protein expression in choroid plexus tumors in children. Acta Neuropathol, 103(1): 1–10. https://doi.org/10.1007/s004010100419

 

  1. Kamaly-Asl ID, Shams N, Taylor MD, 2006, Genetics of choroid plexus tumors. Neurosurg Focus, 20(1): E10. https://doi.org/10.3171/foc.2006.20.1.11

 

  1. Zaky W, Dhall G, Khatua S, et al., 2015, Choroid plexus carcinoma in children: The Head Start experience. Pediatr Blood Cancer, 62(5): 784–789. https://doi.org/10.1002/pbc.25436

 

  1. Mishra A, Srivastava C, Singh SK, et al., 2012, Choroid plexus carcinoma: Case report and review of literature. J Pediatr Neurosci, 7(1): 71–73. https://doi.org/10.4103/1817-1745.97633

 

  1. Carter AB, Price DL, Tucci KA, et al., 2001, Choroid plexus carcinoma presenting as an intraparenchymal mass. Case report. J Neurosurg, 95(6): 1040–1044. https://doi.org/10.3171/jns.2001.95.6.1040

 

  1. Kimura M, Takayasu M, Suzuki Y, et al., 1992, Primary choroid plexus papilloma located in the suprasellar region: Case report. Neurosurgery, 31(3): 563–566. https://doi.org/10.1227/00006123-199209000-00020

 

  1. Rickert CH, Paulus W, 2001, Tumors of the choroid plexus. Microsc Res Tech, 52(1): 104–111. https://doi.org/10.1002/1097-0029(20010101)52: 1<104:AID-JEMT12>3.0.CO;2-3

 

  1. Menon GR, Nair SN, Baldawa SS, et al., 2010, Choroid plexus tumors: An institutional series of 25 patients. Neurol India, 58(3): 429–435. https://doi.org/10.4103/0028-3886.66455

 

  1. Krutilkova V, Trkova M, Fleitz J, et al., 2005, Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer, 41(11): 1597–1603. https://doi.org/10.1016/j.ejca.2005.01.026

 

  1. Meyers SP, Khademian ZP, Chuang SH, et al., 2004, Choroid plexus carcinomas in children: MRI features and patient outcomes. Neuroradiology, 46(9): 770–780. https://doi.org/10.1007/s00234-004-1238-7

 

  1. Wrede B, Liu P, Wolff JEA, 2007, Chemotherapy improves the survival of patients with choroid plexus carcinoma: A meta-analysis of individual cases with choroid plexus tumors. J Neurooncol, 85(3): 345–351. https://doi.org/10.1007/s11060-007-9428-x

 

  1. Bleggi-Torres LF, Urban LA, 2000, Choroid plexus carcinoma: Report of 15 cases. Arq Neuropsiquiatr, 58(2B): 505–511. https://doi.org/10.1590/s0004-282x2000000300017

 

  1. Wrede B, Liu P, Ater J, et al., 2005, Second surgery and the prognosis of choroid plexus carcinoma - Results of a meta-analysis of individual cases. Anticancer Res, 25(6C): 4429–4433.

 

  1. Pierga JY, Kalifa C, Terrier‐Lacombe MJ, et al., 1993, Carcinoma of the choroid plexus: A pediatric experience. Med Pediatr Oncol, 21(7): 480–487. https://doi.org/10.1002/mpo.2950210705

 

  1. Packer RJ, Perilongo G, Johnson D, et al., 1992, Choroid plexus carcinoma of childhood. Cancer, 69(2): 580–585. https://doi.org/10.1002/1097-0142(19920115)69:2<580:aid-cncr2820690250>3.0.co;2-o

 

  1. Gozali AE, Britt B, Shane L, et al., 2012, Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: The Children’s Hospital Los Angeles (CHLA) experience, 1991-2010. Pediatr Blood Cancer, 58(6): 905–909. https://doi.org/10.1002/pbc.23349

 

  1. Rigante L, Borghei-Razavi H, Recinos PF, et al., 2019, An overview of endoscopy in neurologic surgery. Cleve Clin J Med, 86(10): 2–9. https://doi.org/10.3949/CCJM.86.ME.18142

 

  1. Cinalli G, Imperato A, Mirone G, et al., 2017, Initial experience with endoscopic ultrasonic aspirator in purely neuroendoscopic removal of intraventricular tumors. J Neurosurg Pediatr, 19(3): 325–332. https://doi.org/10.3171/2016.10.PEDS16352

 

  1. Sufianov AA, Gaysin IA, Iakimov IA, et al., 2023, Purely endoscopic biportal and monoportal removal of the choroid plexus papilloma of the third ventricle with bilateral spread to the lateral ventricles. Neurosurg Focus Video, 8(2): V7. https://doi.org/10.3171/2023.1.FOCVID22170

 

  1. Sufianov AA, Gaibov SSK, Sufanov RA, 2015, Endoscopic monoportal removal of a choroid plexus papilloma in the posterior third ventricle in a child. J Neurosurg Pediatr, 16(1): 107–111. https://doi.org/10.3171/2014.12.PEDS14306

 

  1. Santos MM, Souweidane MM, 2015, Purely endoscopic resection of a choroid plexus papilloma of the third ventricle: Case report. J Neurosurg Pediatr, 16(1): 54–57. https://doi.org/10.3171/2014.12.PEDS14287

 

  1. Reddy D, Gunnarsson T, Scheinemann K, et al., 2011, Combined staged endoscopic and microsurgical approach of a third ventricular choroid plexus papilloma in an infant. Minim Invasive Neurosurg, 54(5–6): 264–267. https://doi.org/10.1055/S-0031-1287775

 

  1. Gupta P, Sodhi KS, Mohindra S, et al., 2013, Choroid plexus papilloma of the third ventricle: A rare infantile brain tumor. J Pediatr Neurosci, 8(3): 247. https://doi.org/10.4103/1817-1745.123696

 

  1. Spennato P, Onorini N, Vitulli F, et al., 2023, Pure endoscopic ultrasonic removal of choroid plexus papillomas of the third ventricle: Technical report of two cases. Childs Nerv Syst. https://doi.org/10.1007/S00381-023-05979-0

 

  1. Morota N, Fujiyama Y, 2004, Endoscopic coagulation of choroid plexus as treatment for hydrocephalus: Indication and surgical technique. Childs Nerv Syst, 20(11–12): 816–820. https://doi.org/10.1007/S00381-004-0936-0

 

  1. Pople IK, Ettles D, 1995, The role of endoscopic choroid plexus coagulation in the management of hydrocephalus. Neurosurgery, 36(4): 698–702. https://doi.org/10.1227/00006123-199504000-00009

 

  1. Dewan MC, Naftel RP, 2017, The global rise of endoscopic third ventriculostomy with choroid plexus cauterization in pediatric hydrocephalus. Pediatr Neurosurg, 52(6): 401–408. https://doi.org/10.1159/000452809

 

  1. Spennato P, De Rosa A, Meccariello G, et al., 2022, Endoscopic ultrasonic aspiration as alternative to more invasive surgery in initial management of optic pathway gliomas in children. Childs Nerv Syst, 38(7): 1281–1287. https://doi.org/10.1007/S00381-022-05515-6

 

  1. Wright J, Chugh J, Wright CH, et al., 2016, Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors. Neurosurg Focus, 41(4): E14. https://doi.org/10.3171/2016.8.FOCUS16233

 

  1. Sharma M, Balasubramanian S, Silva D, et al., 2016, Laser interstitial thermal therapy in the management of brain metastasis and radiation necrosis after radiosurgery: An overview. Expert Rev Neurother, 16(2): 223–232. https://doi.org/10.1586/14737175.2016.1135736

 

  1. Sharma M, Krivosheya D, Borghei-Razavi H, et al., 2018, Laser interstitial thermal therapy for an eloquent region supratentorial brain lesion. Neurosurg Focus, 44(VideoSuppl2): V4. https://doi.org/10.3171/2018.4.FOCUSVID.17737

 

  1. Mohammadi AM, Schroeder JL, 2014, Laser interstitial thermal therapy in treatment of brain tumors--the NeuroBlate System. Expert Rev Med Devices, 11(2): 109–119. https://doi.org/10.1586/17434440.2014.882225

 

  1. Hong CS, Kundishora AJ, Elsamadicy AA, et al., 2020, Laser interstitial thermal therapy in neuro-oncology applications. Surg Neurol Int, 11: 231. https://doi.org/10.25259/SNI_496_2019

 

  1. Tovar-Spinoza Z, Choi H, 2016, Magnetic resonance-guided laser interstitial thermal therapy: Report of a series of pediatric brain tumors. J Neurosurg Pediatr, 17(6): 723–733. https://doi.org/10.3171/2015.11.PEDS15242

 

  1. Li X, Lovell JF, Yoon J, et al., 2020, Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol, 17(11): 657–674. https://doi.org/10.1038/S41571-020-0410-2

 

  1. Vankayala R, Hwang KC, 2018, Near-infrared-light-activatable nanomaterial-mediated phototheranostic nanomedicines: An emerging paradigm for cancer treatment. Adv Mater, 30(23): 1706320. https://doi.org/10.1002/ADMA.201706320

 

  1. Xu C, Pu K, 2021, Second near-infrared photothermal materials for combinational nanotheranostics. Chem Soc Rev, 50(2): 1111–1137. https://doi.org/10.1039/D0CS00664E

 

  1. Xiong R, Hua D, Van Hoeck J, et al., 2021, Photothermal nanofibres enable safe engineering of therapeutic cells. Nat Nanotechnol, 16(11): 1281–1291. https://doi.org/10.1038/s41565-021-00976-3

 

  1. Jiang Z, Li T, Cheng H, et al., 2021, Nanomedicine potentiates mild photothermal therapy for tumor ablation. Asian J Pharm Sci, 16(6): 738–761. https://doi.org/10.1016/J.AJPS.2021.10.001

 

  1. Li X, Yu S, Lee D, et al., 2018, Facile supramolecular approach to nucleic-acid-driven activatable nanotheranostics that overcome drawbacks of photodynamic therapy. ACS Nano, 12(1): 681–688. https://doi.org/10.1021/acsnano.7b07809

 

  1. Li C, Yang XQ, An J, et al., 2019, A near-infrared light-controlled smart nanocarrier with reversible polypeptide-engineered valve for targeted fluorescence-photoacoustic bimodal imaging-guided chemo-photothermal therapy. Theranostics, 9(25): 7666–7679. https://doi.org/10.7150/THNO.37047

 

  1. Yu Q, Tang X, Zhao W, et al., 2021, Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles. Acta Biomater, 133: 244–256. https://doi.org/10.1016/J.ACTBIO.2021.05.002

 

  1. Ran J, Liu T, Song C, et al., 2023, Rhythm mild-temperature photothermal therapy enhancing immunogenic cell death response in oral squamous cell carcinoma. Adv Healthc Mater, 12(6): e2202360. https://doi.org/10.1002/ADHM.202202360

 

  1. Shang T, Yu X, Han S, et al., 2020, Nanomedicine-based tumor photothermal therapy synergized immunotherapy. Biomater Sci, 8(19): 5241–5259. https://doi.org/10.1039/D0BM01158D

 

  1. Kim HS, Seo M, Park TE, et al., 2022, A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy. J Nanobiotechnol, 20(1): 14. https://doi.org/10.1186/S12951-021-01220-9

 

  1. Vasilev A, Sofi R, Rahman R, et al., 2020, Using light for therapy of glioblastoma multiforme (GBM). Brain Sci, 10(2): 75. https://doi.org/10.3390/BRAINSCI10020075

 

  1. Larjavaara S, Mäntylä R, Salminen T, et al., 2007, Incidence of gliomas by anatomic location. Neuro Oncol, 9(3): 319–325. https://doi.org/10.1215/15228517-2007-016

 

  1. Reyes SJ, González KB, Rodríguez C, et al., 2020, Cancer immunotherapy: An update. Rev Med Chil, 148(7): 970–982. https://doi.org/10.4067/S0034-98872020000700970

 

  1. Shalita C, Hanzlik E, Kaplan S, et al., 2022, Immunotherapy for the treatment of pediatric brain tumors: A narrative review. Transl Pediatr, 11(12): 2040–2056. https://doi.org/10.21037/TP-22-86/COIF

 

  1. Shindo Y, Hazama S, Tsunedomi R, et al., 2019, Novel biomarkers for personalized cancer immunotherapy. Cancers (Basel), 11(9): 1223. https://doi.org/10.3390/CANCERS11091223

 

  1. Estevez-Ordonez D, Gary SE, Atchley TJ, et al., 2022, Immunotherapy for pediatric brain and spine tumors: Current state and future directions. Pediatr Neurosurg, 58: 80–103.

 

https://doi.org/10.1159/000528792

 

  1. Morimoto T, Nakazawa T, Maeoka R, et al., 2023, Natural killer cell-based immunotherapy against glioblastoma. Int J Mol Sci, 24(3): 2111. https://doi.org/10.3390/IJMS24032111

 

  1. Xiao Y, Yu D, 2021, Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther, 221: 107753. https://doi.org/10.1016/j.pharmthera.2020.107753

 

  1. Pollack IF, Jakacki RI, Butterfield LH, et al., 2014, Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas. J Clin Oncol, 32(19): 2050–2058. https://doi.org/10.1200/JCO.2013.54.0526

 

  1. Pollack IF, Jakacki RI, Butterfield LH, et al., 2016, Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas. Neuro Oncol, 18(8): 1157–1168. https://doi.org/10.1093/neuonc/now026

 

  1. Pollack IF, Jakacki RI, Butterfield LH, et al., 2016, Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: Results of a pilot study. J Neurooncol, 130(3): 517–527. https://doi.org/10.1007/S11060-016-2245-3

 

  1. Home - ClinicalTrials.gov. Available from: https:// clinicaltrials.gov [Last accessed on 2023 May 25].

 

  1. NCT00014573, 2013, Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer - Full Text View - ClinicalTrials.gov. Available from: https:// clinicaltrials.gov/ct2/show/nct00014573 [Last accessed on 2023 May 25].

 

  1. Donninger H, Li C, Eaton JW, et al., 2021, Cancer vaccines: Promising therapeutics or an unattainable dream. Vaccines (Basel), 9(6): 668. https://doi.org/10.3390/VACCINES9060668

 

  1. He X, Zhang S, Tian Y, et al., 2023, Research progress of nanomedicine-based mild photothermal therapy in tumor. Int J Nanomedicine, 18: 1433–1468. https://doi.org/10.2147/IJN.S405020

 

  1. Zhang X, Wang X, Hou L, et al., 2023, Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer. Front Pharmacol, 14: 824. https://doi.org/10.3389/FPHAR.2023.1130937/BIBTEX

 

  1. Fang X, Lan H, Jin K, et al., 2022, Nanovaccines for cancer prevention and immunotherapy: An update review. Cancers (Basel), 14(16): 3842. https://doi.org/10.3390/cancers14163842

 

  1. Zhang Y, Lin S, Wang XY, et al., 2019, Nanovaccines for cancer immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 11(5): e1559. https://doi.org/10.1002/WNAN.1559

 

  1. Guo S, Feng J, Li Z, et al., 2023, Improved cancer immunotherapy strategies by nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 15(3): e1873. https://doi.org/10.1002/WNAN.1873

 

  1. Yang J, Zhang C, 2020, Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 12(4): e1612. https://doi.org/10.1002/WNAN.1612

 

  1. Böttcher JP, Bonavita E, Chakravarty P, et al., 2018, NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell, 172(5): 1022–1037.e14. https://doi.org/10.1016/J.CELL.2018.01.004

 

  1. Zhou X, Yu J, Cheng X, et al., 2019, The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming. Nat Immunol, 20(7): 879–889. https://doi.org/10.1038/S41590-019-0405-2

 

  1. Klemm F, Maas RR, Bowman RL, et al., 2020, Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells. Cell, 181(7): 1643–1660.e17. https://doi.org/10.1016/J.CELL.2020.05.007

 

  1. Grabowski MM, Sankey EW, Ryan KJ, et al., 2021, Immune suppression in gliomas. J Neurooncol, 151(1): 3–12. https://doi.org/10.1007/S11060-020-03483-Y

 

  1. Louveau A, Harris TH, Kipnis J, 2015, Revisiting the mechanisms of CNS immune privilege. Trends Immunol, 36(10): 569–577. https://doi.org/10.1016/J.IT.2015.08.006

 

  1. Romero-Suárez S, Del Rio Serrato A, Bueno RJ, et al., 2019, The central nervous system contains ILC1s that differ from NK cells in the response to inflammation. Front Immunol, 10: 2337. https://doi.org/10.3389/FIMMU.2019.02337

 

  1. Calmeiro J, Carrascal MA, Tavares AR, et al., 2020, Dendritic cell vaccines for cancer immunotherapy: The role of human conventional Type 1 dendritic cells. Pharmaceutics, 12(2): 158. https://doi.org/10.3390/PHARMACEUTICS12020158

 

  1. Golubovskaya V, 2022, CAR-T cells targeting immune checkpoint pathway players. Front Biosci (Landmark Ed), 27(4): 121. https://doi.org/10.31083/J.FBL2704121

 

  1. Vitanza NA, Johnson AJ, Wilson AL, et al., 2021, Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: An interim analysis. Nat Med, 27(9): 1544–1552. https://doi.org/10.1038/S41591-021-01404-8

 

  1. NCT03173950, 2023, Immune Checkpoint Inhibitor Nivolumab in People with Recurrent Select Rare CNS Cancers - Full Text View - ClinicalTrials.gov. Available from: https://clinicaltrials.gov/ct2/show/NCT03173950 [Last accessed on 2023 May 25].

 

  1. NCT03638167, 2023, EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors - Full Text View - ClinicalTrials.gov. Available from: https:// clinicaltrials.gov/ct2/show/NCT03638167 [Last accessed on 2023 May 25].

 

  1. NCT04185038, 2023, Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors - Full Text View - ClinicalTrials.gov. Available from: https:// clinicaltrials.gov/ct2/show/NCT04185038 [Last accessed on 2023 May 25].

 

  1. NCT03500991, 2023, HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors - Full Text View - ClinicalTrials.gov. Available from: https:// clinicaltrials.gov/ct2/show/NCT03500991 [Last accessed on 2023 May 25].

 

  1. Tatum AM, Mylin LM, Bender SJ, et al., 2008, CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors. J Immunol, 181(6): 4406–4417. https://doi.org/10.4049/jimmunol.181.6.4406

 

  1. Schell TD, Tevethia SS, 2001, Control of advanced choroid plexus tumors in SV40 T antigen transgenic mice following priming of donor CD8(+) T lymphocytes by the endogenous tumor antigen. J Immunol, 167(12): 6947–6956. https://doi.org/10.4049/jimmunol.167.12.6947

 

  1. Cozza EM, Cooper TK, Budgeon LR, et al., 2015, Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors. Cancer Immunol Immunother, 64(3): 325–336. https://doi.org/10.1007/S00262-014-1635-7

 

  1. Calderwood SK, Theriault JR, Gong J, 2005, Message in a bottle: Role of the 70-kDa heat shock protein family in anti-tumor immunity. Eur J Immunol, 35(9): 2518–2527. https://doi.org/10.1002/EJI.200535002

 

  1. Shevtsov MA, Kim AV, Samochernych KA, et al., 2014, Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children. Onco Targets Ther, 7: 1071–1081. https://doi.org/10.2147/OTT.S62764

 

  1. Bernstock JD, Kang KD, Klinger NV, et al., 2022, Targeting oncometabolism to maximize immunotherapy in malignant brain tumors. Oncogene, 41(19): 2663–2671. https://doi.org/10.1038/s41388-022-02312-y

 

  1. Choi EJ, Sloma EA, Miller AD, 2016, Kir7.1 immunoreactivity in canine choroid plexus tumors. J Vet Diagn Invest, 28(4): 464–468. https://doi.org/10.1177/1040638716650239

 

  1. Reginato A, Girolami D, Menchetti L, et al., 2016, E-cadherin, N-cadherin expression and histologic characterization of canine choroid plexus tumors. Vet Pathol, 53(4): 788–791. https://doi.org/10.1177/0300985815620844

 

  1. NCT04105374, 2023, Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma - Full Text View - ClinicalTrials.gov. Available from: https:// clinicaltrials.gov/ct2/show/NCT04105374 [Last accessed on 2023 May 25].
  2. Ghajar-Rahimi G, Kang KD, Totsch SK, et al., 2022, Clinical advances in oncolytic virotherapy for pediatric brain tumors. Pharmacol Ther, 239: 108193. https://doi.org/10.1016/j.pharmthera.2022.108193

 

  1. Gállego Pérez-Larraya J, García-Moure M, Alonso MM, 2023, Oncolytic virotherapy for the treatment of pediatric brainstem gliomas. Rev Neurol (Paris), 179(5): 475–480. https://doi.org/10.1016/j.neurol.2023.03.016

 

  1. Wang S, Yin Y, Liu S, 2019, Roles of microRNAs during glioma tumorigenesis and progression. Histol Histopathol, 34(3): 213–222. https://doi.org/10.14670/HH-18-040

 

  1. Ghaemmaghami AB, Mahjoubin-Tehran M, Movahedpour A, et al., 2020, Role of exosomes in malignant glioma: MicroRNAs and proteins in pathogenesis and diagnosis. Cell Commun Signal, 18(1): 1–19. https://doi.org/10.1186/S12964-020-00623-9/tables/2

 

  1. Katsila T, Kardamakis D, 2021, The role of microRNAs in gliomas - therapeutic implications. Curr Mol Pharmacol, 14(6): 1004–1012. https://doi.org/10.2174/1874467213666200730115837

 

  1. de Menezes MR, Acioli MEA, da Trindade ACL, et al., 2021, Potential role of microRNAs as biomarkers in human glioblastoma: A mini systematic review from 2015 to 2020. Mol Biol Rep, 48(5): 4647–4658. https://doi.org/10.1007/S11033-021-06423-9

 

  1. Beylerli O, Gareev I, Sufianov A, et al., 2022, The role of microRNA in the pathogenesis of glial brain tumors. Noncoding RNA Res, 7(2): 71–76. https://doi.org/10.1016/j.ncrna.2022.02.005

 

  1. Von Eyss B, Maaskola J, Memczak S, et al., 2012, The SNF2- like helicase HELLS mediates E2F3-dependent transcription and cellular transformation. EMBO J, 31(4): 972–985. https://doi.org/10.1038/EMBOJ.2011.451

 

  1. Myant K, Termanis A, Sundaram AYM, et al., 2011, LSH and G9a/GLP complex are required for developmentally programmed DNA methylation. Genome Res, 21(1): 83–94. https://doi.org/10.1101/GR.108498.110

 

  1. Zemach A, Kim MY, Hsieh PH, et al., 2013, The Arabidopsis nucleosome remodeler DDM1 allows DNA methyltransferases to access H1-containing heterochromatin. Cell, 153(1): 193–205. https://doi.org/10.1016/J.CELL.2013.02.033

 

  1. Rickert CH, Wiestler OD, Paulus W, 2002, Chromosomal imbalances in choroid plexus tumors. Am J Pathol, 160(3): 1105. https://doi.org/10.1016/S0002-9440(10)64931-0

 

  1. de Oliveira Garcia FA, Evangelista AF, Mançano BM, et al., 2023, Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing. Cold Spring Harb Mol Case Stud, 9(1): a006245. https://doi.org/10.1101/MCS.A006245

 

  1. Thomas C, Soschinski P, Zwaig M, et al., 2021, The genetic landscape of choroid plexus tumors in children and adults. Neuro Oncol, 23(4): 650–660. https://doi.org/10.1093/neuonc/noaa267

 

  1. Li Y, Liu H, Li T, et al., 2021, Choroid plexus carcinomas with TP53 germline mutations: Management and outcome. Front Oncol, 11: 751784. https://doi.org/10.3389/fonc.2021.751784/full

 

  1. Thomas C, Metrock K, Kordes U, et al., 2020, Epigenetics impacts upon prognosis and clinical management of choroid plexus tumors. J Neurooncol, 148(1): 39–45. https://doi.org/10.1007/S11060-020-03509-5

 

  1. Pienkowska M, Choufani S, Turinsky AL, et al., 2019, DNA methylation signature is prognostic of choroid plexus tumor aggressiveness. Clin Epigenetics, 11(1): 117. https://doi.org/10.1186/S13148-019-0708-z/figures/8

 

  1. Merino DM, Shlien A, Villani A, et al., 2015, Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups. Clin Cancer Res, 21(1): 184–192. https://doi.org/10.1158/1078-0432.CCR-14-1324

 

  1. Chu BF, Karpenko MJ, Liu Z, et al., 2013, Phase I study of 5-aza-2’-deoxycytidine in combination with valproic acid in non-small-cell lung cancer. Cancer Chemother Pharmacol, 71(1): 115–121. https://doi.org/10.1007/S00280-012-1986-8

 

  1. Akasaki Y, Kikuchi T, Homma S, et al., 2016, Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma. Cancer Immunol Immunother, 65(12): 1499–1509. https://doi.org/10.1007/S00262-016-1905-7/METRICS

 

  1. Zuckerman JE, Gritli I, Tolcher A, et al., 2014, Correlating animal and human phase Ia/Ib clinical data with CALAA- 01, a targeted, polymer-based nanoparticle containing siRNA. Proc Natl Acad Sci U S A, 111(31): 11449–11454. https://doi.org/10.1073/PNAS.1411393111

 

  1. Chaturvedi K, Ganguly K, Kulkarni AR, et al., 2011, Cyclodextrin-based siRNA delivery nanocarriers: A state-of-the-art review. Expert Opin Drug Deliv, 8(11): 1455–1468. https://doi.org/10.1517/17425247.2011.610790

 

  1. Unger C, Häring B, Medinger M, et al., 2007, Phase I and pharmacokinetic study of the (6-maleimidocaproyl) hydrazone derivative of doxorubicin. Clin Cancer Res, 13(16): 4858–4866. https://doi.org/10.1158/1078-0432.CCR-06-2776

 

  1. Liang C, Xu L, Song G, et al., 2016, Emerging nanomedicine approaches fighting tumor metastasis: Animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy. Chem Soc Rev, 45(22): 6250–6269. https://doi.org/10.1039/C6CS00458J

 

  1. Liu H, Xu C, Meng M, et al., 2022, Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer. Acta Biomater, 144: 132–141. https://doi.org/10.1016/J.ACTBIO.2022.03.023

 

  1. Ou K, Xu X, Guan S, et al., 2020, Nanodrug carrier based on poly(Ursolic Acid) with self-anticancer activity against colorectal cancer. Adv Funct Mater, 30(9): 1907857. https://doi.org/10.1002/adfm.201907857

 

  1. Wang R, Yang Y, Yang M, et al., 2020, Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions. J Nanobiotechnology, 18(1): 116. https://doi.org/10.1186/S12951-020-00679-2/FIGURES/7

 

  1. Huang X, Qiu M, Wang T, et al., 2022, Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy. J Nanobiotechnology, 20(1): 93. https://doi.org/10.1186/S12951-022-01300-4

 

  1. Guo ZH, Khattak S, Rauf MA, et al., 2023, Role of nanomedicine-based therapeutics in the treatment of CNS disorders. Molecules, 28(3): 1283. https://doi.org/10.3390/MOLECULES28031283
Conflict of interest
The authors declare that they have no competing interests.
Share
Back to top
Tumor Discovery, Electronic ISSN: 2810-9775 Published by AccScience Publishing